Evidence map›Paper›PMID 30904024›Full record

ArticleBMC palliative care2019

Palliative radiotherapy near the end of life.

Susan Y Wu, Lisa Singer, Lauren Boreta, Michael A Garcia, Shannon E Fogh, Steve E Braunstein

Registry-linked trialAbstract read
In one paragraph

Article in BMC palliative care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04658537 (Advanced Techniques for Single-fraction Palliative Radiotherapy Versus Standard Single Fraction Radiation), which is not on this map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04658537 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

Advanced Techniques for Single-fraction Palliative Radiotherapy Versus Standard Single Fraction Radiation

TypeinterventionalSponsorRoyal North Shore HospitalRan2021 to 2026Enrolled100ConditionsPalliative Radiotherapy, Radiotherapy, Intensity-ModulatedArmsRadiation Therapy
3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. A prospective pilot study to evaluate the impact of palliative radiotherapy in upfront inoperable/chemo unfit patients with extrahepatic biliary tract tumors.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Radiotherapy and palliative care outpatient clinic: a new healthcare integrated model in Italy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susan Y WuDepartment of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, L-75, 1600 Divisadero St., H1031, San Francisco, CA, 94143, USA.
Lisa SingerDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.
Lauren BoretaDepartment of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, L-75, 1600 Divisadero St., H1031, San Francisco, CA, 94143, USA.
Michael A GarciaDepartment of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, L-75, 1600 Divisadero St., H1031, San Francisco, CA, 94143, USA.
Shannon E FoghDepartment of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, L-75, 1600 Divisadero St., H1031, San Francisco, CA, 94143, USA.
Steve E BraunsteinDepartment of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, L-75, 1600 Divisadero St., H1031, San Francisco, CA, 94143, USA. Steve.Braunstein@ucsf.edu.ORCID http://orcid.org/0000-0002-9841-9357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA significant proportion of patients with advanced cancer undergo palliative radiotherapy (RT) within their last 30 days of life. This study characterizes palliative RT at our institution and aims to identify patients who may experience limited benefit from RT due to imminent mortality.

methodsFive hundred and-eighteen patients treated with external beam RT to a site of metastatic disease between 2012 and 2016 were included. Mann-Whitney U and chi-squared tests were used to identify factors associated with RT within 30 days of death (D

resultsMedian age at RT was 63 years (IQR 54-71). Median time from RT to death was 74 days (IQR 33-174). One hundred and twenty-five patients (24%) died within 30 days of RT. D

conclusionsTwenty-four percent of patients received palliative RT within 30 days of death. Additional tools are necessary to help physicians identify patients who would benefit from short treatment courses or alternative interventions to maximize quality at the end of life.

Indexed as

AgedChi-Square DistributionFemaleHumansLogistic ModelsMaleMiddle AgedNeoplasmsPalliative CareQuality of LifeRadiotherapyRetrospective StudiesStatistics, NonparametricCancerEnd-of-life carePalliative radiotherapy

Identifiers

PMID30904024
PMCPMC6431041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.